TP53 and Miyoshi myopathy: Information was available for the 30 MM sample on numerical alterations and secondary events, i.e. somatic mutations (Table 1): therefore, we queried the RNA-seq dataset to evaluate the occurrence of differentially expressed lncRNAs in those MM genetic subtypes (Supplementary Table S3, with the exclusion of FAM46C and P53 due to the low number of samples).